Tag Archives: vaccine

Restrictions flagged for refusing vaccine

Australia’s Deputy Chief Medical Officer Nick Coatsworth has raised the possibility of restrictions for people who refuse to get the COVID-19 vaccine when it is available, if proven successful. Speaking at a press conference on Wednesday, Dr Coatsworth said rules like ‘No jab no pay’, which would restrict government payments, could be brought in to… Read More »

After nearly $1B in research funding, Moderna takes $1.5B coronavirus vaccine order from U.S.

Through its COVID-19 vaccine partnership with the U.S. government, Moderna picked up nearly $ 1 billion in research aid. Now, it’s joining a list of other companies to take a supply order from the federal government. Under a deal worth up to $ 1.525 billion, Moderna agreed to deliver 100 million doses of its mRNA vaccine… Read More »

US government strikes $1.525 billion deal with Moderna for 100 million doses of its experimental Covid-19 vaccine

President Trump announced the deal during a media briefing on Tuesday. Moderna is one of several companies manufacturing the vaccine “at risk,” as the industry calls it, meaning the company is currently making the vaccine before it is approved. Clinical trials are currently underway to test whether it’s safe and effective. Under this contract, worth… Read More »

AstraZeneca confirms Russia vaccine deal days after COVID-19 hacking accusations surface

Last week, Western intelligence officials pegged Russian hackers with an attempt to rip off leading research for a COVID-19 vaccine, linking the would-be thieves with the country’s intelligence services. Russia itself denies involvement in any of those attacks—and with a new licensing deal for AstraZeneca’s COVID-19 shot, the country says it doesn’t need the secrets… Read More »

Pfizer coronavirus vaccine candidate shows early promise

A coronavirus vaccine candidate from pharmaceutical company Pfizer has shown potential in healthy volunteers. Stocks jumped on the announcement Wednesday. The experimental vaccine developed by Pfizer and the biotech firm BioNTech produced promising results in early-stage human trials, in which 45 volunteers were given doses of the vaccine. Each participant received 10, 30, or 100… Read More »